Pacer Advisors Inc. lowered its holdings in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 50.3% in the fourth quarter, HoldingsChannel.com reports. The fund owned 56,568 shares of the technology company’s stock after selling 57,313 shares during the quarter. Pacer Advisors Inc.’s holdings in Veeva Systems were worth $12,628,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. GPS Wealth Strategies Group LLC raised its position in Veeva Systems by 196.4% during the third quarter. GPS Wealth Strategies Group LLC now owns 83 shares of the technology company’s stock worth $25,000 after acquiring an additional 55 shares during the last quarter. Raiffeisen Bank International AG acquired a new position in shares of Veeva Systems in the third quarter valued at approximately $28,000. Board of the Pension Protection Fund acquired a new position in shares of Veeva Systems in the fourth quarter valued at approximately $27,000. Newbridge Financial Services Group Inc. raised its position in shares of Veeva Systems by 322.6% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 131 shares of the technology company’s stock valued at $29,000 after buying an additional 100 shares during the last quarter. Finally, Activest Wealth Management raised its position in shares of Veeva Systems by 3,175.0% in the fourth quarter. Activest Wealth Management now owns 131 shares of the technology company’s stock valued at $29,000 after buying an additional 127 shares during the last quarter. Institutional investors and hedge funds own 88.20% of the company’s stock.
Veeva Systems Stock Performance
Veeva Systems stock opened at $156.17 on Thursday. Veeva Systems Inc. has a 1 year low of $148.05 and a 1 year high of $310.50. The firm has a 50 day moving average price of $172.65 and a 200 day moving average price of $210.11. The company has a market cap of $25.51 billion, a price-to-earnings ratio of 28.87, a PEG ratio of 0.71 and a beta of 0.92.
Insider Transactions at Veeva Systems
In related news, Director Priscilla Hung sold 750 shares of the business’s stock in a transaction that occurred on Thursday, April 30th. The shares were sold at an average price of $155.64, for a total value of $116,730.00. Following the completion of the sale, the director directly owned 3,253 shares in the company, valued at approximately $506,296.92. The trade was a 18.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 10.60% of the company’s stock.
Trending Headlines about Veeva Systems
Here are the key news stories impacting Veeva Systems this week:
- Positive Sentiment: Veeva is expanding its medtech footprint after Smith+Nephew adopted Veeva Quality Cloud to modernize global quality operations and training, a sign of deeper enterprise adoption. VEEV Boosts MedTech Quality Management With Smith+Nephew Partnership
- Positive Sentiment: Investors are also encouraged by Veeva’s expanding partnerships, including Vault CRM adoption and AI-related capabilities tied to the Ostro acquisition, which could support longer-term growth. Can Veeva Systems’ Expanding Partnerships Drive Further Upside?
- Neutral Sentiment: Veeva announced that it will report fiscal Q1 2027 results on June 3, keeping attention on upcoming earnings and guidance rather than any immediate operational change. Veeva to Release Fiscal 2027 First Quarter Results on June 3, 2026
- Neutral Sentiment: Analysts highlighted a mixed valuation picture: recent Q4 strength supports optimism, but questions remain about AI investment, R&D growth, and CRM commitments. How The Veeva Systems (VEEV) Story Is Shifting As Q4 Strength Meets AI And CRM Doubts
- Negative Sentiment: Despite the partnership news, the stock has been falling alongside peers in the software sector, suggesting investor rotation or profit-taking is outweighing near-term positives. CLEAR Secure, Qualys, and Veeva Systems shares plummet, what you need to know
- Negative Sentiment: One market recap also noted Veeva fell even as the broader market advanced, reinforcing that the move looks company-specific or sector-driven rather than macro-related. Veeva Systems (VEEV) Stock Falls Amid Market Uptick: What Investors Need to Know
Analyst Ratings Changes
A number of research firms have recently weighed in on VEEV. Needham & Company LLC cut their price objective on shares of Veeva Systems from $355.00 to $270.00 and set a “buy” rating for the company in a research report on Thursday, March 5th. William Blair reissued an “outperform” rating on shares of Veeva Systems in a research report on Tuesday, March 10th. Citigroup lowered shares of Veeva Systems from a “buy” rating to a “neutral” rating and cut their price objective for the company from $291.00 to $176.00 in a research report on Friday, April 10th. Morgan Stanley boosted their price objective on shares of Veeva Systems from $205.00 to $215.00 and gave the company an “equal weight” rating in a research report on Thursday, March 5th. Finally, Oppenheimer cut their price objective on shares of Veeva Systems from $325.00 to $275.00 and set an “outperform” rating for the company in a research report on Tuesday, February 24th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $278.70.
View Our Latest Stock Report on Veeva Systems
About Veeva Systems
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Featured Articles
- Five stocks we like better than Veeva Systems
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
